²é¿´ÍêÕû°æ±¾: [-- Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ) --]

¿¼²©ÂÛ̳ -> µÚËľüÒ½´óѧ -> Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ) [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

nanafly 2007-01-25 13:46

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ /axIIfx-  
~T) Q$  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© )_/ 5*Ly@  
+cD!1IT:  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© >A@Y$.  
JK.ZdY%  
1.Co-stimulators (or co-stimulating molecules) ^ bEc6`eE  
"M|zv  
2.NK-kB t |~YEQ  
#v<QbA  
3.Immunoglobulin superfamily keB&Bjd&  
L#vI=GpL,r  
4.antigen-presenting cell (APC) 2Ry1b+\  
%/9 EORdeH  
5.death domain /4xki_}  
q$aaA`E%  
6.CCR and CXCR XoA+MuDzpo  
Qx[t /~  
7.Lectin (or mitogen) 8T(e.I  
}#X8@  
8.Clusters of differentiation, CD) jg?x&'u\)  
d6 W SL;$  
9.B7 family AE} )o)B  
}N*_KzPIa  
10.Cytotoxic T lymphocyte, CTL) `F/Tv 5@L  
A<W 6=5h  
11.IL-15 and IL-15 receptor (IL-15R) 6P';DB  
+wkjS r`e  
12.MHC restriction D}v mwg@3  
+"1NC\<*  
13.Affinity-chromatography qbv#I;  
8jyG" %WO  
14.Cyctosprin A, CsA J9=m]R8T  
:H c0b=  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) |O"lNUW   
~V$ |i"  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© aXL{TD:]  
S%Us5`sd  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 uV=Qp1~  
,u/aT5\_  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ 95z]9UL  
0pbtH8~  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 sq;s]@~  
3"P }n  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© =MvjLh"s  
U{VCZ*0cj  
ÃâÒßѧרҵ£º 0lv %`,  
t 89!Ihk  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 0$-xw  
> ss/D^YS  
Ïû»¯ÄÚ¿Æ£º ?`4+cx}n  
X@f "-\  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ yUp,NfS]o  
0D&t!$Ibf  
ѪҺ²¡Ñ§×¨Òµ£º ~t~-A,1  
;vIrGZV<  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿


²é¿´ÍêÕû°æ±¾: [-- Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ) --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us